Inducible Resistance to Vancomycin in Enterococcus faecium D366
- 1 June 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 159 (6), 1095-1104
- https://doi.org/10.1093/infdis/159.6.1095
Abstract
Strain D366, a clinical isolate of Enterococcus faecium, is resistant (minimum inhibitory concentration [MIC] 32 mg/L) to vancomycin. When exponential-phase cultures were exposed to half the MIC of vancomycin, a lag of 3—4 h occurred before growth resumed. Cells preexposed to ½ MICs of vancomycin did not show any lag. Pregrowth of D366 with vancomycin caused resistance to all glycopeptides tested. Pregrowth in vancomycin resulted in synthesis of a 3.95-kDa cytoplasmic-membrane-associated protein. This protein was correlated with resistance in mutants with high-level resistance, in the presence of NaCl, which inhibited the activity of vancomycin, and when several glycopeptides with varying activities were tested. Vancomycin-grown cells appeared abnormal and lysed at a much slower rate than did normal cells. We conclude that (1) vancomycin resistance in D366 is inducible; (2) resistance is correlated with the synthesis of a 39.5-kDa cytoplasmic membrane protein; and (3) this protein may play an additional role in the inhibition of normal lytic functions.Keywords
This publication has 5 references indexed in Scilit:
- Use of Penicillin-binding Proteins for the Identification of EnterococciMicrobiology, 1986
- Hydrolysis of soluble, linear, un-cross-linked peptidoglycans by endogenous bacterial N-acetylmuramoylhydrolasesJournal of Bacteriology, 1984
- Studies on the Mechanism of Intrinsic Resistance to -Lactam Antibiotics in Group D StreptococciMicrobiology, 1983
- Resistance to beta-lactam antibiotics in Streptococcus faeciumAntimicrobial Agents and Chemotherapy, 1982
- Enterococcal bacteremia without endocarditisArchives of Internal Medicine, 1981